Metsera, A Wholly Owned Subsidiary Of Pfizer

This study is testing whether a weekly injection called MET097 helps people with obesity or overweight lose weight. About 225 participants will receive either the drug or a placebo (a dummy injection) for 28 weeks to see which is more effective and safe. The goal is to see if thi…

This study is testing whether a new drug called MET097, given as a monthly injection after initial weekly doses, helps people with obesity or overweight lose weight. About 250 adults will receive either the drug or a placebo (inactive shot) for over a year to see which is more ef…

This study is testing a new drug called MET233, given as a weekly injection, to see if it is safe and helps with weight loss in adults who are overweight or have obesity. Researchers will give the drug to healthy volunteers at different doses to check for side effects and measure…

This study is testing a new weekly injection called MET097 to see if it helps adults with obesity or overweight and type 2 diabetes lose weight and better control their blood sugar. About 133 participants will receive either the real injection or a placebo (a dummy shot) for 28 w…